Breast Cancer
Epidermal Growth Factor Receptor Variant Promotes Tumor Formation
Published in Women's Health Weekly, August 3rd, 2000
According to these researchers, this growth factor variant might also be significant for the development of breast cancer.
"Epidermal growth factor receptor vIII (EGFRvIII) is a tumor-specific, ligand-independent, constitutively active variant of the EGFR," explained C.K. Tang et al. ("Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer," Cancer Res, 2000;60(11):3081-3087).
To test this receptor's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Ovarian Cancer
Low-Dose Oral Contraceptives are as Protective as Older, High-Dose Pills - AIDS Therapies
Mitochondrial Disease Can be Byproduct of Zidovudine During Pregnancy - Obstetrics
Nurses Optimize Care for Pregnant HIV Infected Women and Babies - Adverse Drug Effects
Report Urges Closer Look at Cardiotoxicity of Breast Cancer Drug Trastuzumab (Herceptin) - Breast Cancer
Variability in Cancer Registration in U.K. May Distort Statistics - Etiology
Allergies, Mothers' Periods Linked - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
